Marque D. Todd
Impact in
- Hematology top 10%
- Erythropoietin and Anemia Treatment
- Small Animals top 10%
- Animal testing and alternatives
Papers in
-
- Biosimilars and Bioanalytical Methods 5
- Immunotoxicology and immune responses 2
- Oncology 4
- HER2/EGFR in Cancer Research 2
- Co-authors
- Garry D. Ferroni (1 shared paper)Leo G. Leduc (1 shared paper)Angus M. Sinclair (1 shared paper)Kevin Forsythe (1 shared paper)Steve Elliott (1 shared paper)C. Glenn Begley (1 shared paper)Susan Jane Knox (1 shared paper)B. Lynn Seely (1 shared paper)
- Journals
- Chemical Research in Toxicology (1 paper)Clinical Pharmacology & Therapeutics (1 paper)Regulatory Toxicology and Pharmacology (1 paper)Mutation Research/Genetic Toxicology and Environmental Mutagenesis (1 paper)Cancer (1 paper)
- Partner nations
- United StatesUnited KingdomGermany
In The Last Decade
Marque D. Todd
13 papers receiving 482 citations
Peers
Comparison fields: 5 of 97
- Hematology 78
- Small Animals 46
- Immunology 111
- Cancer Research 57
- Oncology 98
Countries citing papers authored by Marque D. Todd
This map shows the geographic impact of Marque D. Todd's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marque D. Todd with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marque D. Todd more than expected).
Fields of papers citing papers by Marque D. Todd
This network shows the impact of papers produced by Marque D. Todd. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marque D. Todd. The network helps show where Marque D. Todd may publish in the future.
Co-authors
The 25 scholars most cited alongside Marque D. Todd, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2013 | 150 | |
| 2 | 2007 | 84 | |
| 3 | 1998 | 60 | |
| 4 | 1986 | 51 | |
| 5 | 2010 | 36 | |
| 6 | Prolonged treatment of human osteoarthritic chondrocytes with insulin-like growth factor-I stimulates proteoglycan synthesis but not proteoglycan matrix accumulation in alginate cultures. | 2003 | 32 |
| 7 | 2011 | 29 | |
| 8 | 2020 | 25 | |
| 9 | 2014 | 22 | |
| 10 | 2010 | 17 | |
| 11 | 2010 | 14 | |
| 12 | 1999 | 13 | |
| 13 | 2013 | 3 |
About Marque D. Todd
Marque D. Todd is a scholar working on Immunology, Oncology, Radiology, Nuclear Medicine and Imaging, Cancer Research and Reproductive Medicine, having authored 13 papers that have together received 536 indexed citations. Recurring topics across this work include Biosimilars and Bioanalytical Methods (5 papers), Monoclonal and Polyclonal Antibodies Research (3 papers), Carcinogens and Genotoxicity Assessment (2 papers), Immunotoxicology and immune responses (2 papers), HER2/EGFR in Cancer Research (2 papers), Statistical Methods in Clinical Trials (1 paper), Listeria monocytogenes in Food Safety (1 paper) and Molecular Biology Techniques and Applications (1 paper). The work is most often cited by research in Hematology (78 citations), Small Animals (46 citations), Immunology (111 citations), Cancer Research (57 citations) and Oncology (98 citations). Marque D. Todd has collaborated with scholars based in United States, United Kingdom and Germany. Frequent co-authors include Garry D. Ferroni, Leo G. Leduc, Angus M. Sinclair, Kevin Forsythe, Steve Elliott, C. Glenn Begley, Susan Jane Knox, B. Lynn Seely, Richard F. Loeser and Xavier Gidrol. Their work appears in journals such as Chemical Research in Toxicology, Clinical Pharmacology & Therapeutics, Regulatory Toxicology and Pharmacology, Mutation Research/Genetic Toxicology and Environmental Mutagenesis and Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.